Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $388.39 million. The enterprise value is $867.76 million.

Market Cap	388.39M
Enterprise Value	867.76M

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

ESPR has 200.20 million shares outstanding. The number of shares has increased by 34.63% in one year.

Current Share Class	200.20M
Shares Outstanding	200.20M
Shares Change (YoY)	+34.63%
Shares Change (QoQ)	+0.72%
Owned by Insiders (%)	0.93%
Owned by Institutions (%)	58.94%
Float	198.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	20.21
PS Ratio	1.42
Forward PS	1.01
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-9.05%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$881,990
Profits Per Employee	-$316,079
Employee Count	304
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.44% in the last 52 weeks. The beta is 0.82, so ESPR's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+5.44%
50-Day Moving Average	1.29
200-Day Moving Average	1.66
Relative Strength Index (RSI)	70.62
Average Volume (20 Days)	6,416,753

Short Selling Information

The latest short interest is 23.13 million, so 11.55% of the outstanding shares have been sold short.

Short Interest	23.13M
Short Previous Month	22.10M
Short % of Shares Out	11.55%
Short % of Float	11.66%
Short Ratio (days to cover)	4.77

Income Statement

In the last 12 months, ESPR had revenue of $268.13 million and -$96.09 million in losses. Loss per share was -$0.49.

Revenue	268.13M
Gross Profit	131.89M
Operating Income	-27.51M
Pretax Income	n/a
Net Income	-96.09M
EBITDA	-27.41M
EBIT	-27.51M
Loss Per Share	-$0.49

Full Income Statement

Balance Sheet

The company has $114.63 million in cash and $594.00 million in debt, giving a net cash position of -$479.37 million or -$2.39 per share.

Cash & Cash Equivalents	114.63M
Total Debt	594.00M
Net Cash	-479.37M
Net Cash Per Share	-$2.39
Equity (Book Value)	-426.21M
Book Value Per Share	-2.17
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 49.19%, with operating and profit margins of -10.26% and -35.84%.

Gross Margin	49.19%
Operating Margin	-10.26%
Pretax Margin	-35.84%
Profit Margin	-35.84%
EBITDA Margin	-10.22%
EBIT Margin	-10.26%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.63%
Shareholder Yield	-34.63%
Earnings Yield	-24.74%
FCF Yield	n/a

Analyst Forecast

The average price target for ESPR is $6.50, which is 235.05% higher than the current price. The consensus rating is "Buy".

Price Target	$6.50
Price Target Difference	235.05%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	26.39%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a